JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) - USD ($)				1 Months Ended					3 Months Ended		12 Months Ended	68 Months Ended
	Aug. 11, 2017	Aug. 11, 2017	Aug. 03, 2012	Oct. 27, 2017	Aug. 31, 2017	Aug. 25, 2016	Jun. 01, 2016	Mar. 31, 2016	Mar. 31, 2018	Sep. 30, 2017	Dec. 31, 2016	Mar. 31, 2018	Dec. 31, 2017	Jul. 14, 2017	Mar. 31, 2017	Aug. 31, 2016
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures			$ 6,000,000						$ 6,000,000			$ 6,000,000		$ 1,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares)			600,000
Joint Venture Investments In Non Voting Preferred Ownership Units			5,000,000
Development Activities Monthly Fee			$ 63,000
Joint Venture, Operating Expenses, Inter Company Transactions									427,000			10,078,000
Joint Venture, Operating Expenses Allocated To Company									427,000			8,466,000
Percentage Of Non Royalty Income		5.00%
Conversion of Stock, Shares Converted	3,500,000							1,500,000
Conversion of Stock, Shares Issued								120,000
Joint Venture Method Investment Ownership Percentage			60.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						33,088
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 10.70
Management Fees							$ 80,000
Professional Fees							$ 10,000
Accrued Professional Fees					$ 20,000
Conversion of Stock, Amount Converted	$ 3,500,000
Conversion of Stock, Amount Issued	1,000,000
Interest Payable									104,000			104,000	$ 68,000
Other Assets, Current									$ 76,000			76,000	$ 98,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			83,480
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage									50.00%
MrHolliman [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				14,126
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 10.70
Ownership As Converted [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage									65.11%
OwnershipAsConvertedIncludingOptionsAndWarrants [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage				64.31%
Series B2 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity						$ 946,000										$ 946,000
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs						1,012,000
Proceeds from Issuance of Preferred Stock and Preference Stock			$ 15,000			946,000
Conversion of Stock, Amount Issued	$ 1,000,000
Stock Issued During Period, Shares, Acquisitions	93,458
Stock Issued During Period, Value, Acquisitions	$ 1,000,000
Series B1 And B2 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage			62.20%
Series B1 Preferred Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity						946,000
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs						1,012,000
Proceeds from Issuance of Preferred Stock and Preference Stock						946,000					$ 946,000
Payments of Stock Issuance Costs						$ 66,000
Stock Issued During Period, Shares, New Issues						94,537
Management Fees					$ 300,000						300,000
Professional Fees											60,000
Management Fee Expense										$ 150,000	$ 250,000
Other Commitment, Due in Second Year									$ 150,000			150,000
Accrued Professional Fees									160,000			160,000
Other Assets, Current															$ 50,000
Revolving Credit Facility [Member]
Related Party Transaction [Line Items]
Long-term Line of Credit									1,660,000			1,660,000
Interest Payable									60,000			60,000
Common Stock [Member]
Related Party Transaction [Line Items]
Joint Venture Losses Recognition Criteria, Common Ownership Equity									$ 0			$ 0
Preferred Stock [Member]
Related Party Transaction [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent									100.00%			100.00%
Noncontrolling Interest [Member]
Related Party Transaction [Line Items]
Noncash or Part Noncash Acquisition, Other Liabilities Assumed												$ 667,000,000
Maximum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage								64.00%
Minimum [Member]
Related Party Transaction [Line Items]
Joint Venture Method Investment Ownership Percentage								60.00%
Exclusive License Agreement [Member]
Related Party Transaction [Line Items]
Percentage Of Royalty Payment		3.00%
Annual Maintenance Payments		$ 25,000
Exclusive License Agreement [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Milestone Payments		500,000
Royalty Expense		1,000,000
Exclusive License Agreement [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Milestone Payments		50,000
Royalty Expense		$ 500,000
Lipimetix [Member]
Related Party Transaction [Line Items]
Joint Venture Investments Common Ownership Units, Co-venture (in shares)			400,000
Ownership Percentage Co-venture			40.00%
Noncash or Part Noncash Acquisition, Other Liabilities Assumed									$ 667,000
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)			$ 378,000						$ 378,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross									81,479
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price									$ 1.07
Lipimetix [Member] | Ownership As Converted [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage			69.75%						60.00%			60.00%
Voting Common Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures			$ 1,000,000
Non Voting Preferred Ownership Units [Member]
Related Party Transaction [Line Items]
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures			$ 5,000,000